A detailed history of Frontier Capital Management CO LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Frontier Capital Management CO LLC holds 179,154 shares of UTHR stock, worth $66.1 Million. This represents 0.64% of its overall portfolio holdings.

Number of Shares
179,154
Previous 37,636 376.02%
Holding current value
$66.1 Million
Previous $12 Million 435.53%
% of portfolio
0.64%
Previous 0.13%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$311.04 - $363.55 $44 Million - $51.4 Million
141,518 Added 376.02%
179,154 $64.2 Million
Q2 2024

Aug 14, 2024

BUY
$228.26 - $319.04 $1.05 Million - $1.47 Million
4,598 Added 13.92%
37,636 $12 Million
Q1 2024

May 15, 2024

SELL
$210.76 - $249.51 $161,442 - $191,124
-766 Reduced 2.27%
33,038 $7.59 Million
Q4 2023

Feb 14, 2024

BUY
$214.88 - $256.94 $8,595 - $10,277
40 Added 0.12%
33,804 $7.43 Million
Q3 2023

Nov 14, 2023

SELL
$211.82 - $248.24 $327,685 - $384,027
-1,547 Reduced 4.38%
33,764 $7.63 Million
Q2 2023

Aug 14, 2023

SELL
$205.19 - $232.99 $5.34 Million - $6.06 Million
-26,021 Reduced 42.43%
35,311 $7.79 Million
Q1 2023

May 15, 2023

SELL
$212.99 - $276.17 $35.2 Million - $45.7 Million
-165,455 Reduced 72.96%
61,332 $13.7 Million
Q4 2022

Feb 14, 2023

BUY
$205.95 - $280.43 $8.17 Million - $11.1 Million
39,657 Added 21.19%
226,787 $63.1 Million
Q3 2022

Nov 14, 2022

SELL
$203.3 - $244.17 $5.19 Million - $6.24 Million
-25,551 Reduced 12.01%
187,130 $39.2 Million
Q2 2022

Jul 20, 2022

BUY
$174.81 - $241.14 $5.8 Million - $8.01 Million
33,203 Added 18.5%
212,681 $50.1 Million
Q1 2022

Apr 14, 2022

SELL
$166.16 - $213.96 $2.81 Million - $3.62 Million
-16,910 Reduced 8.61%
179,478 $32.2 Million
Q4 2021

Jan 19, 2022

BUY
$184.32 - $216.08 $20.1 Million - $23.5 Million
108,924 Added 124.54%
196,388 $42.4 Million
Q3 2021

Oct 19, 2021

SELL
$179.86 - $214.88 $4.07 Million - $4.86 Million
-22,611 Reduced 20.54%
87,464 $16.1 Million
Q2 2021

Aug 09, 2021

SELL
$170.47 - $211.93 $3.18 Million - $3.95 Million
-18,630 Reduced 14.47%
110,075 $19.7 Million
Q1 2021

May 13, 2021

BUY
$153.94 - $174.85 $15.3 Million - $17.4 Million
99,579 Added 341.89%
128,705 $21.5 Million
Q4 2020

Jan 19, 2021

SELL
$101.87 - $151.79 $371,214 - $553,122
-3,644 Reduced 11.12%
29,126 $4.42 Million
Q3 2020

Nov 16, 2020

SELL
$99.9 - $121.13 $1.3 Million - $1.58 Million
-13,023 Reduced 28.44%
32,770 $3.31 Million
Q2 2020

Jul 17, 2020

BUY
$92.74 - $125.82 $572,762 - $777,064
6,176 Added 15.59%
45,793 $5.54 Million
Q1 2020

Apr 16, 2020

BUY
$79.39 - $115.35 $3.15 Million - $4.57 Million
39,617 New
39,617 $3.76 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.8B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Frontier Capital Management CO LLC Portfolio

Follow Frontier Capital Management CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frontier Capital Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frontier Capital Management CO LLC with notifications on news.